Lizzie Grosset
About Lizzie Grosset
Lizzie Grosset is the VP of Global Market Access with over 20 years of experience in the pharmaceutical industry, specializing in global pricing and market access.
Lizzie Grosset's Role as VP of Global Market Access
Lizzie Grosset holds the position of Vice President of Global Market Access. In this role, she leverages her extensive experience in the pharmaceutical industry to develop and execute strategies that ensure market access for various products. She specializes in global pricing and market access, focusing on creating value propositions and developing payer evidence to support product access across different regions.
Lizzie Grosset's Pharmaceutical Industry Experience
With over 20 years of experience in the pharmaceutical industry, Lizzie Grosset has worked at prominent companies such as AstraZeneca, Allergan (now AbbVie), and GSK. Her roles in these companies have encompassed both global and marketing functions, demonstrating a broad understanding of the industry's complexities and requirements.
Expertise in Global Pricing and Market Access Strategies
Lizzie Grosset is known for her expertise in global pricing and market access. She has led the development of comprehensive strategies for products in phase 2/3 development, including creating payer evidence and value propositions. Her work ensures that pharmaceutical products are priced and positioned effectively in different markets, facilitating broader patient access.
Experience in Diverse Therapeutic Areas
Lizzie Grosset has substantial experience in a variety of therapeutic areas, including nephrology/kidney disease, cardiovascular disease, immunology, rare and orphan diseases, and non-alcoholic steatohepatitis (NASH). Her diverse background allows her to navigate the specific market access challenges associated with each therapeutic area, driving successful outcomes.
Development of Payer Advisory Board Programs
Lizzie Grosset has developed and led comprehensive payer advisory board programs across multiple regions, including the US, EU, AsiaPac, and LatAm. These programs address the needs and perspectives of different payer archetypes, ensuring that global market access strategies are tailored to regional requirements and stakeholders.